Financial statements Provisus Badania Kliniczne

Balance sheet of Provisus Badania Kliniczne

Company age:
Age:
5 y. 8 m. 14 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of PROVISUS BADANIA KLINICZNE

Year
2020
2021
2023
Total assets 119 320,72 434 951,67 2 171 746,57
A. Fixed assets 0,00 142 911,21 1 257 945,64
B. Current assets 119 320,72 292 040,46 913 800,93
C. Share capital contributions (basic funds) - 0,00 0,00
D. Own shares (stocks) - 0,00 0,00
Total liabilities 119 320,72 434 951,67 2 171 746,57
A. Equity 5 928,16 177 680,66 1 648 246,45
B. Liabilities and provisions for liabilities 113 392,56 257 271,01 523 500,12
I. Long-term liabilities - 0,00 165 020,79
II. Short-term liabilities - 249 471,01 350 979,33
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.